Loading clinical trials...
Loading clinical trials...
Tricuspid regurgitation (TR) is a common complication following cardiac implantable electronic device (CIED) implantation, with severe TR being associated with increased rates of heart failure hospita...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Haiyan Wang
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07516145 · Tricuspid Regurgitation (TR), Valvular Heart Diseases, and more
NCT07250529 · Atrial Fibrillation (AF), Pacemaker Therapy, and more
NCT07464106 · Tricuspid Regurgitation, Tricuspid Valve Insufficiency, and more
NCT07433504 · Severe or Greater Tricuspid Regurgitation
The First Affiliated Hospital of Shandong First Medical University
Jinan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions